TD Asset Management Inc decreased its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 2.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 182,952 shares of the financial services provider’s stock after selling 5,091 shares during the period. TD Asset Management Inc’s holdings in Aflac were worth $19,294,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the company. NorthRock Partners LLC grew its position in shares of Aflac by 1.5% in the 1st quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider’s stock worth $725,000 after acquiring an additional 95 shares in the last quarter. Valued Wealth Advisors LLC lifted its stake in Aflac by 24.4% during the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 97 shares during the last quarter. Duncan Williams Asset Management LLC lifted its stake in Aflac by 5.0% during the second quarter. Duncan Williams Asset Management LLC now owns 2,065 shares of the financial services provider’s stock worth $218,000 after purchasing an additional 98 shares during the last quarter. Phillips Wealth Planners LLC boosted its holdings in Aflac by 1.5% in the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider’s stock worth $711,000 after purchasing an additional 100 shares during the period. Finally, Stiles Financial Services Inc increased its stake in Aflac by 3.4% during the second quarter. Stiles Financial Services Inc now owns 3,070 shares of the financial services provider’s stock valued at $324,000 after purchasing an additional 100 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Aflac
In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total transaction of $102,570.00. Following the transaction, the director owned 25,105 shares of the company’s stock, valued at approximately $2,575,019.85. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is owned by corporate insiders.
Aflac Stock Performance
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The business had revenue of $5.91 billion during the quarter. On average, analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac declared that its board has initiated a stock repurchase plan on Tuesday, August 12th that authorizes the company to repurchase 100,000,000 shares. This repurchase authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
Aflac Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th were issued a $0.58 dividend. The ex-dividend date of this dividend was Wednesday, August 20th. This represents a $2.32 annualized dividend and a yield of 2.2%. Aflac’s dividend payout ratio is presently 52.61%.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on AFL shares. JPMorgan Chase & Co. raised their price target on shares of Aflac from $96.00 to $100.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 8th. Morgan Stanley lifted their target price on Aflac from $108.00 to $113.00 and gave the company an “equal weight” rating in a research note on Monday, August 18th. Barclays reaffirmed an “underweight” rating and set a $102.00 target price (up from $100.00) on shares of Aflac in a report on Wednesday, October 8th. Evercore ISI set a $110.00 price objective on Aflac and gave the company an “underperform” rating in a research report on Thursday, October 9th. Finally, Wall Street Zen raised Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. Three research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus target price of $109.45.
View Our Latest Stock Analysis on AFL
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- What to Know About Investing in Penny Stocks
- This AI Chip Giant Could Be the Market’s Next Big Winner
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Expert Stock Trading Psychology Tips
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.